BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang J, Wang J, Guo L, Kong X, Yang J, Zheng F, Zhang L, Huang Y. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol Cells. 2010;29:9-19. [PMID: 20016947 DOI: 10.1007/s10059-010-0001-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang B, Ma X, Zhao L, Zhou X, Ma Y, Sun H, Yang Y, Chen B. Injection of basic fibroblast growth factor together with adipose-derived stem cell transplantation: improved cardiac remodeling and function in myocardial infarction. Clin Exp Med 2016;16:539-50. [DOI: 10.1007/s10238-015-0383-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Qiu R, Cai A, Dong Y, Zhou Y, Yu D, Huang Y, Zheng D, Rao S, Feng Y, Mai W. SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects. J Biomed Sci 2012;19:99. [PMID: 23170833 DOI: 10.1186/1423-0127-19-99] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
3 Rogers TB, Pati S, Gaa S, Riley D, Khakoo AY, Patel S, Wardlow RD 2nd, Frederick CA, Hall G, He LP, Lederer WJ. Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes. J Mol Cell Cardiol 2011;50:346-56. [PMID: 20837021 DOI: 10.1016/j.yjmcc.2010.09.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
4 Lewis FC, Cottle BJ, Shone V, Marazzi G, Sassoon D, Tseng CCS, Dankers PYW, Chamuleau SAJ, Nadal-Ginard B, Ellison-Hughes GM. Transplantation of Allogeneic PW1pos/Pax7neg Interstitial Cells Enhance Endogenous Repair of Injured Porcine Skeletal Muscle. JACC Basic Transl Sci 2017;2:717-36. [PMID: 30062184 DOI: 10.1016/j.jacbts.2017.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Suzuki G. Translational research of adult stem cell therapy. World J Cardiol 2015; 7(11): 707-718 [PMID: 26635920 DOI: 10.4330/wjc.v7.i11.707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gallina C, Turinetto V, Giachino C. A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome. Stem Cells Int 2015;2015:765846. [PMID: 26074978 DOI: 10.1155/2015/765846] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 11.3] [Reference Citation Analysis]
7 Kizilay Mancini O, Lora M, Cuillerier A, Shum-Tim D, Hamdy R, Burelle Y, Servant MJ, Stochaj U, Colmegna I. Mitochondrial Oxidative Stress Reduces the Immunopotency of Mesenchymal Stromal Cells in Adults With Coronary Artery Disease. Circ Res 2018;122:255-66. [PMID: 29113965 DOI: 10.1161/CIRCRESAHA.117.311400] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
8 Nazari-Shafti TZ, Neuber S, Garcia Duran A, Xu Z, Beltsios E, Seifert M, Falk V, Stamm C. Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease. Stem Cells Transl Med 2020;9:1558-69. [PMID: 32761804 DOI: 10.1002/sctm.19-0432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Broughton KM, Sussman MA. Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps. Circ Res. 2016;118:867-880. [PMID: 26941423 DOI: 10.1161/circresaha.115.305227] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
10 Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015). Stem Cell Res Ther. 2016;7:82. [PMID: 27259550 DOI: 10.1186/s13287-016-0341-0] [Cited by in Crossref: 115] [Cited by in F6Publishing: 114] [Article Influence: 19.2] [Reference Citation Analysis]
11 Sears V, Ghosh G. Harnessing mesenchymal stem cell secretome: Effect of extracellular matrices on proangiogenic signaling. Biotechnol Bioeng 2020;117:1159-71. [PMID: 31956977 DOI: 10.1002/bit.27272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tavakolian Ferdousie V, Mohammadi M, Hassanshahi G, Khorramdelazad H, Khanamani Falahati-Pour S, Mirzaei M, Allah Tavakoli M, Kamiab Z, Ahmadi Z, Vazirinejad R, Shahrabadi E, Koniari I, Kounis NG, Esmaeili Nadimi A. Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. Int J Cardiol 2017;233:23-8. [PMID: 28189264 DOI: 10.1016/j.ijcard.2017.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
13 Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;10:244-258. [PMID: 22385653 DOI: 10.1016/j.stem.2012.02.005] [Cited by in Crossref: 549] [Cited by in F6Publishing: 530] [Article Influence: 54.9] [Reference Citation Analysis]
14 Wang H, Liu Z, Li D, Guo X, Kasper FK, Duan C, Zhou J, Mikos AG, Wang C. Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction. J Cell Mol Med 2012;16:1310-20. [PMID: 21838774 DOI: 10.1111/j.1582-4934.2011.01409.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
15 Bain O, Detela G, Kim H, Mason C, Mathur A, Wall IB. Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: implications for cell retention at physiologic sites. Regenerative Medicine 2014;9:153-65. [DOI: 10.2217/rme.13.91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Li Z, Wei H, Deng L, Cong X, Chen X. Expression and secretion of interleukin-1β, tumour necrosis factor-α and interleukin-10 by hypoxia- and serum-deprivation-stimulated mesenchymal stem cells. FEBS J 2010;277:3688-98. [PMID: 20681988 DOI: 10.1111/j.1742-4658.2010.07770.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
17 Sala V, Crepaldi T. Novel therapy for myocardial infarction: can HGF/Met be beneficial? Cell Mol Life Sci 2011;68:1703-17. [DOI: 10.1007/s00018-011-0633-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
18 Pourrajab F, Forouzannia SK, Tabatabaee SA. Molecular characteristics of bone marrow mesenchymal stem cells, source of regenerative medicine. International Journal of Cardiology 2013;163:125-31. [DOI: 10.1016/j.ijcard.2011.11.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
19 Pourrajab F, Forouzannia SK, Tabatabaee SA. WITHDRAWN: Molecular Characteristics of Bone Marrow Mesenchymal Stem Cells: An Appealing Source for Regenerative Medicine. Heart Lung Circ 2012:S1443-9506(12)00258-2. [PMID: 22939816 DOI: 10.1016/j.hlc.2012.04.021] [Reference Citation Analysis]
20 Mastri M, Lin H, Lee T. Enhancing the efficacy of mesenchymal stem cell therapy. World J Stem Cells 2014; 6(2): 82-93 [PMID: 24772236 DOI: 10.4252/wjsc.v6.i2.82] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
21 Zhu P, Liu J, Shi J, Zhou Q, Liu J, Zhang X, Du Z, Liu Q, Guo Y. Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarction. J Cell Mol Med. 2015;19:2232-2243. [PMID: 26081690 DOI: 10.1111/jcmm.12610] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
22 Laube M, Stolzing A, Thome UH, Fabian C. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth. Int J Biochem Cell Biol 2016;74:18-32. [PMID: 26928452 DOI: 10.1016/j.biocel.2016.02.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
23 Micheu MM, Scarlatescu AI, Scafa-Udriste A, Dorobantu M. The Winding Road of Cardiac Regeneration-Stem Cell Omics in the Spotlight. Cells 2018;7:E255. [PMID: 30544622 DOI: 10.3390/cells7120255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Luo R, Lu Y, Liu J, Cheng J, Chen Y. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases. Biomed Pharmacother 2019;109:2022-34. [PMID: 30551458 DOI: 10.1016/j.biopha.2018.11.068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
25 Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116:1413-1430. [PMID: 25858066 DOI: 10.1161/circresaha.116.303614] [Cited by in Crossref: 256] [Cited by in F6Publishing: 167] [Article Influence: 36.6] [Reference Citation Analysis]
26 Jahandideh S, Maghsood F, Ghahhari NM, Lotfinia M, Mohammadi M, Johari B, Kadivar M. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome. Tissue and Cell 2017;49:597-602. [DOI: 10.1016/j.tice.2017.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
27 Mao Q, Lin C, Gao J, Liang X, Gao W, Shen L, Kang L, Xu B. Mesenchymal stem cells overexpressing integrin-linked kinase attenuate left ventricular remodeling and improve cardiac function after myocardial infarction. Mol Cell Biochem 2014;397:203-14. [PMID: 25134935 DOI: 10.1007/s11010-014-2188-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
28 Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 2016;96:1127-68. [PMID: 27335447 DOI: 10.1152/physrev.00019.2015] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 32.2] [Reference Citation Analysis]
29 Tang J, Wang J, Zheng F, Kong X, Guo L, Yang J, Zhang L, Huang Y. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 2010;339:107-18. [PMID: 20058054 DOI: 10.1007/s11010-009-0374-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
30 Elnakish MT, Kuppusamy P, Khan M. Stem cell transplantation as a therapy for cardiac fibrosis. J Pathol 2013;229:347-54. [PMID: 23011894 DOI: 10.1002/path.4111] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
31 Liao SY, Tse HF. Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? Stem Cell Res Ther 2013;4:151. [PMID: 24476362 DOI: 10.1186/scrt381] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
32 Samper E, Diez-juan A, Montero JA, Sepúlveda P. Cardiac Cell Therapy: Boosting Mesenchymal Stem Cells Effects. Stem Cell Rev and Rep 2013;9:266-80. [DOI: 10.1007/s12015-012-9353-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
33 Zhang Y, Zhang R, Li Y, He G, Zhang D, Zhang F. Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia. Mol Biol Rep 2012;39:285-93. [PMID: 21553056 DOI: 10.1007/s11033-011-0737-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
34 Zhang L, Wang JN, Tang JM, Kong X, Yang JY, Zheng F, Guo LY, Huang YZ, Zhang L, Tian L. VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep. 2012;39:5085-5093. [PMID: 22161247 DOI: 10.1007/s11033-011-1304-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
35 Gu L, Yu T, Liu J, Lu Y. Evaluation of the mechanism of cordyceps polysaccharide action on rat acute liver failure. Arch Med Sci 2020;16:1218-25. [PMID: 32864011 DOI: 10.5114/aoms.2020.94236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci. 2017;18. [PMID: 28841158 DOI: 10.3390/ijms18091852] [Cited by in Crossref: 378] [Cited by in F6Publishing: 369] [Article Influence: 75.6] [Reference Citation Analysis]
37 Fatkhudinov T, Bolshakova G, Arutyunyan I, Elchaninov A, Makarov A, Kananykhina E, Khokhlova O, Murashev A, Glinkina V, Goldshtein D, Sukhikh G. Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int 2015;2015:746873. [PMID: 25685158 DOI: 10.1155/2015/746873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Karpov AA, Udalova DV, Pliss MG, Galagudza MM. Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells. Cell Prolif. 2017;50. [PMID: 27878916 DOI: 10.1111/cpr.12316] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
39 Zhang Z, Long C, Guan Y, Song M. Hepatocyte growth factor intervention to reduce myocardial injury and improve cardiac function on diabetic myocardial infarction rats. Eur J Histochem 2020;64. [PMID: 32909423 DOI: 10.4081/ejh.2020.3142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ma J, Zhao Y, Sun L, Sun X, Zhao X, Sun X, Qian H, Xu W, Zhu W. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med 2017;6:51-9. [PMID: 28170176 DOI: 10.5966/sctm.2016-0038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 139] [Article Influence: 23.3] [Reference Citation Analysis]
41 Pankajakshan D, Agrawal DK. Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration. J Biomed Technol Res 2014;1. [PMID: 28890954 DOI: 10.19104/jbtr.2014.107] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
42 Huang L, Ma W, Ma Y, Feng D, Chen H, Cai B. Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? Int J Biol Sci. 2015;11:238-245. [PMID: 25632267 DOI: 10.7150/ijbs.10725] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 11.3] [Reference Citation Analysis]
43 Lee JW, Lee SH, Youn YJ, Ahn MS, Kim JY, Yoo BS, Yoon J, Kwon W, Hong IS, Lee K. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci. 2014;29:23-31. [PMID: 24431901 DOI: 10.3346/jkms.2014.29.1.23] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
44 Lu M, Zhao S, Liu Q, Jiang S, Song P, Qian H, Zhang Y, Ling J, Yan C, Cheng H, Ma N, Zhao H, Liu Y. Transplantation with autologous mesenchymal stem cells after acute myocardial infarction evaluated by magnetic resonance imaging: an experimental study. J Thorac Imaging 2012;27:125-35. [PMID: 21336180 DOI: 10.1097/RTI.0b013e31820446fa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Maleiner B, Tomasch J, Heher P, Spadiut O, Rünzler D, Fuchs C. The Importance of Biophysical and Biochemical Stimuli in Dynamic Skeletal Muscle Models. Front Physiol 2018;9:1130. [PMID: 30246791 DOI: 10.3389/fphys.2018.01130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
46 Nguyen-Truong M, Hematti P, Wang Z. Current status of myocardial restoration via the paracrine function of mesenchymal stromal cells. Am J Physiol Heart Circ Physiol 2021;321:H112-27. [PMID: 34085844 DOI: 10.1152/ajpheart.00217.2021] [Reference Citation Analysis]
47 Nasser M, Wu Y, Danaoui Y, Ghosh G. Engineering microenvironments towards harnessing pro-angiogenic potential of mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl 2019;102:75-84. [PMID: 31147047 DOI: 10.1016/j.msec.2019.04.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
48 Kim J, Shapiro L, Flynn A. The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease. Pharmacology & Therapeutics 2015;151:8-15. [DOI: 10.1016/j.pharmthera.2015.02.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
49 Neuber S, Emmert MY, Nazari-Shafti TZ. Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis. Int J Mol Sci 2021;22:13000. [PMID: 34884805 DOI: 10.3390/ijms222313000] [Reference Citation Analysis]
50 Gu W, Hong X, Potter C, Qu A, Xu Q. Mesenchymal stem cells and vascular regeneration. Microcirculation. 2017;24. [PMID: 27681821 DOI: 10.1111/micc.12324] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
51 You Y, Kobayashi K, Colak B, Luo P, Cozens E, Fields L, Suzuki K, Gautrot J. Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair. Biomaterials 2021;269:120356. [PMID: 33189358 DOI: 10.1016/j.biomaterials.2020.120356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
52 Richardson JD, Nelson AJ, Zannettino AC, Gronthos S, Worthley SG, Psaltis PJ. Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev Rep 2013;9:281-302. [PMID: 22529015 DOI: 10.1007/s12015-012-9366-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
53 Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, Tsai MY, Luo J, Chang C. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology 2013;57:1550-63. [PMID: 23150236 DOI: 10.1002/hep.26135] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
54 Cavallini C, Zannini C, Olivi E, Tassinari R, Taglioli V, Rossi M, Poggi P, Chatgilialoglu A, Simonazzi G, Alviano F, Bonsi L, Ventura C. Restoring In Vivo-Like Membrane Lipidomics Promotes Exosome Trophic Behavior from Human Placental Mesenchymal Stromal/Stem Cells. Cell Transplant 2018;27:55-69. [PMID: 29562775 DOI: 10.1177/0963689717723016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
55 Accomasso L, Gallina C, Turinetto V, Giachino C. Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview. Stem Cells Int 2016;2016:7920358. [PMID: 26839568 DOI: 10.1155/2016/7920358] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
56 Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010;62:1156-66. [PMID: 20828588 DOI: 10.1016/j.addr.2010.08.010] [Cited by in Crossref: 142] [Cited by in F6Publishing: 124] [Article Influence: 11.8] [Reference Citation Analysis]
57 Li L, Chen X, Wang WE, Zeng C. How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? Stem Cells Int. 2016;2016:9682757. [PMID: 26681958 DOI: 10.1155/2016/9682757] [Cited by in Crossref: 78] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
58 Xu SY, Wang F, Wei G, Wang B, Yang JY, Huang YZ, Zhang L, Zheng F, Guo LY, Wang JN. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression. Cancer Gene Ther. 2013;20:690-694. [PMID: 24336114 DOI: 10.1038/cgt.2013.70] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
59 Fatkhudinov TKh, Bol'shakova GB, Goldshtein DV, Sukhikh GT. Mechanisms of therapeutic activity of multipotent cells in heart diseases. Bull Exp Biol Med 2014;156:535-43. [PMID: 24771445 DOI: 10.1007/s10517-014-2392-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
60 Peng Y, Xuan M, Zou J, Liu H, Zhuo Z, Wan Y, Cheng B. Freeze-dried rat bone marrow mesenchymal stem cell paracrine factors: a simplified novel material for skin wound therapy. Tissue Eng Part A 2015;21:1036-46. [PMID: 25343727 DOI: 10.1089/ten.TEA.2014.0102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
61 Sassoli C, Zecchi-Orlandini S, Formigli L. Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration. Cells 2012;1:832-50. [PMID: 24710532 DOI: 10.3390/cells1040832] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
62 Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011;50:280-289. [PMID: 20727900 DOI: 10.1016/j.yjmcc.2010.08.005] [Cited by in Crossref: 296] [Cited by in F6Publishing: 274] [Article Influence: 24.7] [Reference Citation Analysis]
63 Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L, Yang Y. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res 2020;116:353-67. [PMID: 31119268 DOI: 10.1093/cvr/cvz139] [Cited by in Crossref: 45] [Cited by in F6Publishing: 61] [Article Influence: 22.5] [Reference Citation Analysis]
64 Ouma GO, Jonas RA, Usman MH, Mohler ER 3rd. Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc Med 2012;17:174-92. [PMID: 22496126 DOI: 10.1177/1358863X12438270] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
65 Ranganath SH, Tong Z, Levy O, Martyn K, Karp JM, Inamdar MS. Controlled Inhibition of the Mesenchymal Stromal Cell Pro-inflammatory Secretome via Microparticle Engineering. Stem Cell Reports 2016;6:926-39. [PMID: 27264972 DOI: 10.1016/j.stemcr.2016.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
66 Zhang S, Chen S, Li Y, Liu Y. Melatonin as a promising agent of regulating stem cell biology and its application in disease therapy. Pharmacol Res. 2017;117:252-260. [PMID: 28042087 DOI: 10.1016/j.phrs.2016.12.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]